Fineline Cube

Follow:
14691 Articles
Policy / Regulatory

7th National VBP Round Venue Moved to Nanjing from Shanghai

CompanyDrug

Sino Biopharmaceutical’s TQ-B3101 Accepted by NMPA for ROS1+ NSCLC Treatment

CompanyDrug

Ascletis Pharma Presents ASC22 Phase IIb Results for Chronic Hepatitis B at ILC 2022

CompanyDrug

Cosunter Pharma’s HBV Surface Antigen Inhibitor GST-HG121 Approved for Phase I Trial

CompanyDeals

Sanyou Biopharmaceuticals and Dragon Sail Form Strategic Partnership for Global Biopharma Services

Medical Device

NMPA Approves Senscure’s Cryoablation Catheter and Kangduo’s Laparoscopic Surgery System

CompanyDeals

Westlake Therapeutics Secures RMB 100 Million in Series A+ Funding for Red Cell Therapy Pipeline

CompanyDeals

PhenoVision Bio Secures Angel Funding for Spatial Multi-Omics Technology Platform

CompanyDrug

GSK Launches Nucala in China for Eosinophilic Granulomatosis with Polyangiitis

CompanyDeals

Genor Biopharma and Abogen Biosciences Collaborate on Cancer mRNA Therapies

Drug

Kexing Pharmaceutical’s Oral COVID-19 Drug SHEN26 Accepted for Clinical Trial Review

CompanyDeals

Sunshine Guojian Pharmaceutical Signs Licensing Deal for Cipterbin ADC Development